Monoclonal antibodies are a type of biologic medication that can treat moderate to severe inflammatory bowel disease (IBD) by targeting specific inflammatory processes in your body. Your doctor might ...
Capturing Unicorns: Targeting Cancers With TP53 Mutations, RAS Alterations Beyond G12C, and MTAP Loss—No Target Is Out of the Realm of Possibility Bispecific antibodies (bsAbs) have emerged as a novel ...
GV20 Therapeutics uses its proprietary STEAD (Simultaneous Target Evaluation and Antibody Discovery) platform to decode the natural B cell responses in patient tumors to rapidly identify novel targets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results